Voleon Capital Management LP Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Voleon Capital Management LP purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 12,962 shares of the healthcare conglomerate's stock, valued at approximately $6,557,000.

Other large investors also recently made changes to their positions in the company. Sugarloaf Wealth Management LLC raised its stake in UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock worth $4,025,000 after buying an additional 1,193 shares during the period. Signal Advisors Wealth LLC raised its stake in shares of UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after purchasing an additional 1,051 shares during the period. Waycross Partners LLC raised its stake in shares of UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after purchasing an additional 658 shares during the period. Czech National Bank raised its stake in shares of UnitedHealth Group by 6.1% in the 4th quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate's stock valued at $100,937,000 after purchasing an additional 11,426 shares during the period. Finally, Lmcg Investments LLC raised its holdings in UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock worth $19,210,000 after acquiring an additional 4,022 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. JPMorgan Chase & Co. cut their price objective on UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Oppenheimer cut their price target on UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a report on Monday, April 21st. Erste Group Bank raised UnitedHealth Group to a "strong-buy" rating in a report on Wednesday, April 16th. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Finally, Barclays dropped their target price on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Buy" and a consensus target price of $596.86.

UnitedHealth Group Trading Down 2.6 %

NYSE:UNH opened at $409.23 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $372.49 billion, a price-to-earnings ratio of 26.40, a PEG ratio of 1.37 and a beta of 0.61. The firm has a fifty day simple moving average of $499.59 and a two-hundred day simple moving average of $532.08. UnitedHealth Group Incorporated has a 12 month low of $409.10 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the business posted $6.91 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.05%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is currently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.